You have 9 free searches left this month | for more free features.

INNO-206

Showing 1 - 25 of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Solid Tumour Trial in Santa Monica (INNO-206)

Completed
  • Malignant Solid Tumour
  • INNO-206
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Advanced Solid Tumor Trial in Santa Monica (aldoxorubicin)

Completed
  • Advanced Solid Tumor
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Advanced Solid Tumors Trial in Los Angeles (aldoxorubicin)

Completed
  • Advanced Solid Tumors
  • Los Angeles, California
    Samuel Oschin Comprehensive Cancer Institute
Jan 27, 2022

Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)

Completed
  • Metastatic Solid Tumors
  • Scottsdale, Arizona
  • +1 more
Jan 27, 2022

Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)

Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Kaposi's Sarcoma, HIV Positive, AIDS Trial in New Orleans (aldoxorubicin)

Completed
  • Kaposi's Sarcoma
  • +2 more
  • New Orleans, Louisiana
    Louisiana State University Health Science Center
Jan 27, 2022

Glioblastoma Trial in United States (aldoxorubicin)

Completed
  • Glioblastoma
  • Duarte, California
  • +3 more
Jan 27, 2022

Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma Trial in Worldwide (Aldoxorubicin, Investigator's Choice

Completed
  • Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
  • Aldoxorubicin
  • Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
  • Birmingham, Alabama
  • +73 more
Mar 28, 2022

Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)

Withdrawn
  • Non Small Cell Lung Cancer
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

Not yet recruiting
  • Melanoma
  • ABP 206
  • +2 more
  • (no location specified)
Jun 8, 2023

Achondroplasia Trial in Worldwide (BMN 111, Placebo)

Completed
  • Achondroplasia
  • BMN 111
  • Placebo
  • Oakland, California
  • +15 more
Dec 15, 2022

Organ Protection Trial (Lidocaine, Normal saline (NS))

Not yet recruiting
  • Organ Protection
  • (no location specified)
Aug 13, 2022

Colorectal Tumor Trial in Shanghai

Recruiting
  • Colorectal Neoplasm
    • Shanghai, Shanghai, China
      Ruijin hospital
    Apr 15, 2022

    Amputation, Upper Limb Trial (MyoTrain, Motor Imagery)

    Not yet recruiting
    • Amputation
    • Upper Limb
    • MyoTrain
    • Motor Imagery
    • (no location specified)
    May 25, 2023

    Gastritis Trial in Seoul (AD-206 20mg, Esomeprazole 20mg, AD-206 40mg)

    Completed
    • Gastritis
    • AD-206 20mg
    • +3 more
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jan 11, 2021

    Rehabilitation Status of Cerebral Palsy and Anxiety of Their

    Completed
    • Cerebral Palsy
    • +2 more
      • Istanbul, Atasehir, Turkey
        Pinar Akpinar
      Jun 4, 2021

      Solid Tumor Trial in Tucson, Newport Beach, Houston (Tilsotolimod, Nivolumab, Ipilimumab)

      Active, not recruiting
      • Solid Tumor
      • Tucson, Arizona
      • +2 more
      Feb 15, 2022

      Health Literacy Level Trial in Ankara (Health Literacy Education)

      Completed
      • Health Literacy Level
      • Health Literacy Education
      • Ankara, Çubuk, Turkey
        Ankara Yıldırım Beyazıt University
      May 5, 2021

      Paget's Disease of Bone Trial (alendronate)

      Completed
      • Paget's Disease of Bone
      • (no location specified)
      Feb 1, 2022

      Coronary Artery Disease Trial in Shenyang (Biolimus, Powerline)

      Completed
      • Coronary Artery Disease
      • Biolimus
      • Powerline
      • Shenyang, Liaoning, China
        General Hospital of Northern Theater Command
      Sep 15, 2021

      Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

      Not yet recruiting
      • Unresectable Metastatic Colorectal Cancer
      • (no location specified)
      Oct 25, 2023

      Fibromyalgia Trial in Seville (Extra Virgin Olive oil-supplemented Mediterranean Diet Intervention, Olive oil-supplemented

      Active, not recruiting
      • Fibromyalgia
      • Extra Virgin Olive oil-supplemented Mediterranean Diet Intervention
      • Olive oil-supplemented Mediterranean Diet Intervention
      • Seville, Spain
        Pronacera Therapeutics Laboratory
      Jun 27, 2023

      Latent Tuberculosis Trial in Dourados (BCG)

      Not yet recruiting
      • Latent Tuberculosis
      • BCG
      • Dourados, Mato Grosso Do Sul, Brazil
        Roberto Oliveira
      Sep 13, 2022